Patent 6963010 was granted and assigned to MediQuest Therapeutics on November, 2005 by the United States Patent and Trademark Office.
The disclosed invention provides new polyamine analogs and derivatives containing a hydrophobic region and a polyamine region as well as methods and compositions for their use.